Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laser System Treats Inflammatory Acne Vulgaris

By HospiMedica staff writers
Posted on 16 Jul 2003
A laser system that can increase collagen production by 99.5% and effectively treat many vascular disorders can also treat inflammatory acne vulgaris. More...
This application has been cleared by the US Food and Drug Administration (FDA).

The system is a fast-pulsed dye laser that emits a wavelength of yellow light directly over problem areas. This heats small blood vessels, allowing them to open and release healing mediators that, in turn, encourage the natural healing process and stimulate collagen production. In a trial at Hammersmith Hospital (London, UK) involving 41 patients, a single five-minute treatment with the laser system resulted in a 50% improvement in acne lesion count. In addition, about 25% of the patients were acne-free after treatment.

"This noninvasive laser targets the skin's small blood vessels, so it does not cut or burn the outermost layer of the epidermis,” said Dr. Suzanne Kilmer, past president of the American Society for Laser Medicine. "Thus, no anesthesia is required. There are no side effects, treatment is pain-free, and the patient has no downtime as a result of this procedure.”

Called NLite-V, the laser system was developed by USA Photonics, Inc. (Nanuet, NY, USA), using the company's Smartpulse technology. The company states that NLite is the first major advance in the field of dermatology in more than 30 years.




Related Links:
USA Photonics

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.